FR2968995B1 - Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage - Google Patents
Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusageInfo
- Publication number
- FR2968995B1 FR2968995B1 FR1060655A FR1060655A FR2968995B1 FR 2968995 B1 FR2968995 B1 FR 2968995B1 FR 1060655 A FR1060655 A FR 1060655A FR 1060655 A FR1060655 A FR 1060655A FR 2968995 B1 FR2968995 B1 FR 2968995B1
- Authority
- FR
- France
- Prior art keywords
- oral administration
- pharmaceutical composition
- prevent measurement
- present
- prevent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1060655A FR2968995B1 (fr) | 2010-12-16 | 2010-12-16 | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
PCT/EP2011/072933 WO2012080408A1 (fr) | 2010-12-16 | 2011-12-15 | Composition pharmaceutique pour une administration orale destinée à empêcher un mauvais usage |
TW100146612A TWI538698B (zh) | 2010-12-16 | 2011-12-15 | 防止誤用之口服醫藥組合物 |
JP2013543787A JP5960159B2 (ja) | 2010-12-16 | 2011-12-15 | 誤用を防止することを目的とする経口投与用医薬組成物 |
ARP110104692A AR084299A1 (es) | 2010-12-16 | 2011-12-15 | Composicion farmaceutica para una administracion por via oral destinada a evitar el mal uso |
EP11799420.2A EP2651391B1 (fr) | 2010-12-16 | 2011-12-15 | Composition pharmaceutique destinee a eviter l'abus par des tiers |
US13/918,149 US20130280326A1 (en) | 2010-12-16 | 2013-06-14 | Pharmaceutical composition for oral administration intended to prevent misuse |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1060655A FR2968995B1 (fr) | 2010-12-16 | 2010-12-16 | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2968995A1 FR2968995A1 (fr) | 2012-06-22 |
FR2968995B1 true FR2968995B1 (fr) | 2013-03-22 |
Family
ID=44269233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1060655A Expired - Fee Related FR2968995B1 (fr) | 2010-12-16 | 2010-12-16 | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
Country Status (7)
Country | Link |
---|---|
US (1) | US20130280326A1 (fr) |
EP (1) | EP2651391B1 (fr) |
JP (1) | JP5960159B2 (fr) |
AR (1) | AR084299A1 (fr) |
FR (1) | FR2968995B1 (fr) |
TW (1) | TWI538698B (fr) |
WO (1) | WO2012080408A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9616029B2 (en) * | 2014-03-26 | 2017-04-11 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release coated reservoir solid dosage form |
FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705691A (en) * | 1985-11-18 | 1987-11-10 | The Procter & Gamble Co. | Beverage opacifier |
GB2279961A (en) * | 1993-06-22 | 1995-01-18 | Ici Plc | Paint containing white opacifier |
EP1005863A1 (fr) * | 1998-12-04 | 2000-06-07 | Synthelabo | Formes galeniques a liberation controlee contenant un hypnotique a activite courte ou un sel de ce compose |
FR2787715B1 (fr) * | 1998-12-23 | 2002-05-10 | Synthelabo | Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables |
JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
EP1064937A1 (fr) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Formes pharmaceutiques à liberation controllée comprenant un hypnotique à courte duree ou une des ses sels |
US6759073B2 (en) * | 2001-07-02 | 2004-07-06 | The Procter & Gamble Co. | Compositions and methods for stabilization and enhanced viscosity |
KR20040044990A (ko) * | 2001-09-26 | 2004-05-31 | 파마시아 코포레이션 | 구강내 붕해성 발데콕시브 조성물 |
US20050147670A1 (en) * | 2002-05-29 | 2005-07-07 | Impax Laboratories Inc. | Oral disintegrating dosage forms |
FR2848855B1 (fr) | 2002-12-23 | 2005-02-11 | Aventis Pharma Sa | Compositions pour administration orale de principes actifs necessitant un masquage du gout |
US20070196476A1 (en) * | 2004-04-30 | 2007-08-23 | Withiam Michael C | Rapidly dissolving tablets comprising low surface area titanium dioxide |
RU2010128019A (ru) * | 2007-12-08 | 2012-01-20 | Байер Шеринг Фарма Акциенгезельшафт (DE) | Пероральная диспергируемая таблетка |
JP2009179603A (ja) * | 2008-01-31 | 2009-08-13 | Kyorin Pharmaceut Co Ltd | 口腔内速崩壊性錠剤及びその製造方法 |
US9005660B2 (en) * | 2009-02-06 | 2015-04-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
-
2010
- 2010-12-16 FR FR1060655A patent/FR2968995B1/fr not_active Expired - Fee Related
-
2011
- 2011-12-15 EP EP11799420.2A patent/EP2651391B1/fr active Active
- 2011-12-15 JP JP2013543787A patent/JP5960159B2/ja not_active Expired - Fee Related
- 2011-12-15 AR ARP110104692A patent/AR084299A1/es not_active Application Discontinuation
- 2011-12-15 WO PCT/EP2011/072933 patent/WO2012080408A1/fr active Application Filing
- 2011-12-15 TW TW100146612A patent/TWI538698B/zh not_active IP Right Cessation
-
2013
- 2013-06-14 US US13/918,149 patent/US20130280326A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2651391B1 (fr) | 2019-01-23 |
TWI538698B (zh) | 2016-06-21 |
JP2013545784A (ja) | 2013-12-26 |
FR2968995A1 (fr) | 2012-06-22 |
EP2651391A1 (fr) | 2013-10-23 |
JP5960159B2 (ja) | 2016-08-02 |
US20130280326A1 (en) | 2013-10-24 |
TW201306879A (zh) | 2013-02-16 |
WO2012080408A1 (fr) | 2012-06-21 |
AR084299A1 (es) | 2013-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122786T1 (el) | Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης | |
UA111717C2 (uk) | Склад для перорального введення і ліпофільні солі метилналтрексону | |
EA201300146A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ | |
EA201491607A1 (ru) | Модуляторы толлподобных рецепторов | |
EA201270619A1 (ru) | Применение бетанехола для лечения ксеростомии | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
EA201390662A1 (ru) | Фармацевтическая композиция, содержащая дутастерид | |
IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
EA201590805A1 (ru) | Композиция с немедленным и пролонгированным высвобождением | |
CY1115556T1 (el) | Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη | |
EA201291211A1 (ru) | Фармацевтические композиции, содержащие гидроморфон и налоксон | |
EA201490222A1 (ru) | Комбинированные составы на основе дарунавира | |
EA201490223A1 (ru) | Составы на основе дарунавира | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
MA35816B1 (fr) | Dérivés d'aniline, leur préparation et leur application thérapeutique | |
MX2014001368A (es) | Soluciones anti-inflamatorias estables para inyección. | |
EA201270728A1 (ru) | Пуриновые соединения | |
EA201200485A1 (ru) | Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол | |
MA34709B1 (fr) | Compositions pharmaceutiques | |
EA201391643A1 (ru) | Составы с замедленным высвобождением парацетамола | |
EA201400444A1 (ru) | Производные 2-оксопиперидинила | |
FR2968995B1 (fr) | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
ST | Notification of lapse |
Effective date: 20220808 |